Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Clinical Model Identifies H1N1 Influenza-Related Pneumonia

By HospiMedica International staff writers
Posted on 24 Mar 2011
A diagnostic model based on five clinical criteria effectively distinguishes H1N1 influenza-related pneumonia from inter-pandemic community-acquired pneumonia (CAP), reports a new study.

Researchers at Nottingham University Hospitals NHS Trust (United Kingdom) studied data collected by the UK Influenza Clinical Information Network (FLU-CIN) on 1,046 adults admitted to 75 hospitals with confirmed H1N1 influenza, between May 2009 and January 2010. More...
Of these, 254 were found to have H1N1 influenza-related pneumonia on admission. Clinical and epidemiological information from these 254 patients were compared with that from 648 adults with CAP who were admitted to hospital between September 2008 and June 2010, excluding those admitted during the period of the pandemic.

The results of the study showed that although both groups had similar levels of in-hospital mortality (11.4% for the H1N1 cohort, compared to 14.0% in the CAP cohort), they differed significantly on a number of clinical characteristics. Analysis revealed five clinical criteria that distinguished between the cohorts; these included age younger than 65 years, bilateral radiographic change, mental orientation (i.e., awareness of time, place, and person), a low leucocyte count, and body temperature of over 38 °C. By assigning a score of one point for each of these five clinical criteria, the team found that a score of 4 or 5 gave a positive likelihood ratio of 9.0 for predicting H1N1 influenza-related pneumonia, while a score of 0 or 1 gave a positive likelihood ratio of 75.7 for excluding it. The study was published in the March 2011 issue of Thorax.

"A model based on five simple clinical criteria… allows the early discrimination of H1N1 influenza-related pneumonia from CAP following hospital admission and confers confidence to the instigation of early empirical antiviral therapy,” concluded lead author consultant respiratory physician Wei Shen Lim, MD, and colleagues of the department of respiratory medicine.

Related Links:
Nottingham University Hospitals NHS Trust




New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Syringe Pump
SP50 Series
New
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.